Pazopanib Impurity 1 | CAS 6269-91-6 - Request Quote
Pazopanib Impurity 1
| SZ CAT No: | SZ-P013006 |
| CAS No | 6269-91-6 |
| Mol.F. | C7H8N2O4S |
| Mol.Wt. | 216.2 |
| Inv. Status | In Stock |
| Rel. CAS No | 126148-19-4 (Na salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Pazopanib Impurity 1 is chemically 2-Methyl-5-nitrobenzenesulfonamide. Pazopanib Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Pazopanib Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pazopanib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 6269-91-6
Purchase 6269-91-6
Order 6269-91-6
Enquire 6269-91-6
price of 6269-91-6
6269-91-6 Supplier
6269-91-6 Manufacturer
6269-91-6 Exporter
buy high quality Pazopanib Impurity 1
Purchase Pazopanib Impurity 1
Pazopanib Impurity 1 suppliers
Pazopanib Impurity 1 manufacturers
Pazopanib Impurity 1 price
Order Pazopanib Impurity 1
Enquire Pazopanib Impurity 1
Pazopanib Impurity 1 cost
Pazopanib Impurity 1 Supplier
Pazopanib Impurity 1 Distributor
Pazopanib Impurity 1 for Method Validation
Pazopanib Reference Standard
Pazopanib Impurity 1 for ANDA Filing
Pazopanib Impurity 1 for Forced Degradation Studies
Pazopanib Impurity 1 Identification Standards
Pazopanib Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


